Dublin, Nov. 20, 2020 (GLOBE NEWSWIRE) — The “Pipeline Analysis of Phase III Medical Therapeutic Devices: The Potential…
All patients were treated from Jan. 17, 2017, to Dec. 21, 2018. Each patient was called after seven days, and a follow-up visit was scheduled after three, six and 12 months.
Overall, the team reported, the recurrence of any…
The company will focus on the invention, creation and monetization of proprietary medical technologies to solve major health challenges.
University of Alabama at Birmingham
The company will focus on the invention, creation…
Medtronic has shared more clinical data on the use of its cryoballoon ablation device as a first-line treatment for paroxysmal atrial fibrillation, with the New England Journal of Medicine on Monday publishing findings from…
Guidelines recommend a trial of one or more antiarrhythmic drugs before catheter ablation is considered in patients with atrial fibrillation. However, first-line ablation may be more effective in maintaining sinus rhythm.
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that the primary results of the Medtronic-sponsored STOP AF First clinical trial…
DALLAS, Nov. 16, 2020 — A one-month treatment of dual anti-platelet therapy is safe and as effective as a longer duration of therapy at preventing cardiac events in patients one year after stent placement, according to late-breaking research…
Gov. Greg Abbott told the ABC station in Houston that Texas will receive a shipment of the drug that helped cure President Donald Trump.
Melissa Lavasani never expected to grow psychedelic mushrooms in her Washington, D.C., home or become a force behind a successful measure that makes cultivation and possession of plant and fungi medicines the lowest priority for local police…
